Infectious immune triggers
Recent group-A streptococcal infection is common, while tuberculosis and diverse bacterial, viral or fungal infections matter according to exposure and geography.
Recognise erythema nodosum as a tender septal panniculitis across skin tones, investigate likely infectious, inflammatory, medicine and pregnancy triggers proportionately, and identify atypical nodules needing biopsy or urgent reassessment.
Erythema nodosum is the most common panniculitis. It represents a reactive inflammatory pattern in the septa between fat lobules rather than infection of the skin itself. Tender nodules emerge over days, most often on both shins, and may feel more extensive beneath the skin than their colour suggests. They do not usually suppurate or ulcerate. As inflammation resolves over three to six weeks, lesions change through bruise-like tones and may leave temporary post-inflammatory hyperpigmentation, especially in richly pigmented skin, but not the depressed scarring expected from destructive lobular panniculitis.
The eruption is a signpost to a trigger, not an automatic diagnosis of sarcoidosis. Ask about recent sore throat, cough, tuberculosis contact or travel, diarrhoea or blood, abdominal pain, joint symptoms, pregnancy possibility, new medicines and systemic constitutional change. Examine throat, cervical nodes, chest, abdomen, joints and lower-limb circulation. The yield of testing is highest when guided by local epidemiology and this history: throat sampling and antistreptolysin titres answer different time points, while tuberculosis tests require exposure and imaging context.
Recent group-A streptococcal infection is common, while tuberculosis and diverse bacterial, viral or fungal infections matter according to exposure and geography.
Sarcoidosis and inflammatory bowel disease generate systemic inflammation that can manifest as reactive septal panniculitis, sometimes before the underlying disorder is recognised.
Hormonal immune change during pregnancy and selected medicines, including some contraceptives and antimicrobials, can precede a characteristic otherwise unexplained episode.
No driver is found in many self-limited cases, while persistent constitutional or atypical disease occasionally signals lymphoma, leukaemia or another malignancy.
Antigenic stimulation produces a cell-mediated inflammatory response within subcutaneous tissue rather than direct microbial invasion of each nodule.
Oedema and mixed inflammatory cells widen connective-tissue partitions between adipose lobules, creating deep tenderness and poorly defined palpable swelling.
Small radial histiocytic aggregates around clefts can appear within septa and support the pattern, although they are not independently diagnostic.
Because classic disease is mainly septal and lacks destructive vasculitis, nodules flatten without suppuration, fat necrosis or depressed permanent scarring.
Deep ill-defined painful lumps arise symmetrically over anterior lower legs, with overlying warmth and colour change but no central fluctuation.
Active red, violaceous or brown nodules flatten through green-yellow or darker pigment over weeks and resolve without ulcer or depressed scar.
Bilateral ankle pain and oedematous periarticular swelling commonly accompanies the eruption and may impair walking despite preserved joint architecture.
Acute erythema nodosum, ankle periarthritis and bilateral hilar lymphadenopathy strongly supports a characteristic sarcoidosis presentation.
Ulceration, drainage, marked asymmetry, livedoid change, cold tissue or a persistent solitary mass argues against ordinary erythema nodosum.
Sore throat, cough, night sweats, bowel bleeding, weight loss, pregnancy or a new medicine redirects investigation towards a specific trigger.
Unilateral expanding heat, portal of entry, fluctuance, toxicity or gas suggests bacterial infection rather than symmetrical sterile nodules.
Posterior calf nodules that ulcerate, with lobular granulomatous inflammation and vasculitis, favour erythema induratum or a related process.
A tender venous cord or unilateral calf swelling and thrombosis risk requires vascular examination and ultrasound rather than panniculitis treatment.
Oily draining necrotic nodules with pancreatic disease or ulcerative panniculitis with protease-inhibitor deficiency indicates lobular fat destruction.
Persistent firm asymmetric nodules with constitutional decline or cytopenia can represent lymphoma or leukaemic infiltration and require deep biopsy.
Deep shin tenderness and ankle periarthritis can limit walking, sleep, work and exercise for several weeks despite a favourable skin outcome.
Bruise-like brown or darker marks may remain after inflammation, particularly in richly pigmented skin, and cause distress despite eventual fading.
Failure to investigate a coherent trigger can delay treatment of tuberculosis, sarcoidosis, inflammatory bowel disease, infection or haematological malignancy.
Unnecessary antibiotics promote adverse effects and resistance, while NSAIDs or premature corticosteroids can worsen renal, gastrointestinal, pregnancy, IBD or infectious risk.
The palpable lesion often extends beyond visible colour because inflammation lies within subcutaneous septa rather than the superficial epidermis or dermis.
Brown or bruise-like remnants can persist after tenderness and heat resolve, particularly in darker skin, and should not automatically trigger systemic treatment.
Periarticular oedema may cause more functional limitation than the nodules and is a useful clue to the acute sarcoid Löfgren phenotype.
An antistreptolysin response supports recent streptococcal exposure but cannot establish that viable throat bacteria remain or require antibiotics today.
Classic erythema nodosum preserves the surface; breakdown or drainage should prompt deep infection, vasculitis, pancreatic panniculitis or another diagnosis.
When tissue is necessary, an incisional sample with ample fat answers the septal-versus-lobular question better than a superficial routine punch.
Calling every tender red lower-leg lesion cellulitis and prescribing repeated antibiotics for a symmetrical non-infectious eruption.
Equating erythema nodosum with sarcoidosis without asking about streptococcus, TB, IBD, pregnancy and medicines.
Treating an isolated ASO titre as evidence of current infection requiring antibiotics.
Using NSAIDs despite active bowel inflammation, renal injury, ulcer bleeding, anticoagulation or pregnancy risk.
Taking a superficial punch that misses subcutaneous fat in an atypical persistent nodule.
Starting systemic corticosteroid before infection and malignancy have been adequately considered.
Escalating treatment for residual hyperpigmentation after heat and tenderness have resolved.
Your practice draft is saved in this browser.
A young adult has bilateral tender shin nodules, painful swollen ankles and bilateral hilar lymphadenopathy on chest radiograph, without ulceration or major respiratory compromise. Which syndrome best unifies the findings?
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes
Treatment follows severity and cause. A streptococcal infection, active tuberculosis or inflammatory bowel disease receives its own evidence-based therapy; erythema nodosum does not justify empirical antibiotics without infection evidence. Most skin pain improves with reduced weight-bearing, elevation and analgesia. Oral corticosteroid can mask infection and is rarely needed; it belongs to specialist care only after infection and malignancy have been addressed. Failure to improve should trigger a fresh diagnosis rather than a longer sequence of symptomatic prescriptions.
Avoid active peptic ulcer or bleeding, significant renal disease, NSAID-sensitive asthma and the final trimester of pregnancy; review cardiovascular, anticoagulant and interacting-drug risk and avoid during active IBD when it may worsen bowel disease.